Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Product Development

Takeda's patients

How Takeda is integrating the patient perspective into drug development

January 26, 2015 8:00 AM UTC

Takeda Pharmaceutical Co. Ltd. is trying to incorporate patient input throughout the drug development continuum, from early stage candidate selection to clinical trial design. While the pharma is hopeful that FDA will provide clarity on how it plans to integrate patient perspectives into drug reviews, Takeda isn't letting regulatory uncertainty slow down its efforts.

The pharma believes increased patient engagement will result in faster clinical trial recruitment and produce treatments that patients actually want and need...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article